ALNYLAM PHARMACEUTICALS, INC. Other Non-Current Assets
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Other Non-Current Assets of $65.13 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Assets, Noncurrent $65.13M.
- 2025-12-31: Other Assets, Noncurrent $59.46M.
- 2025-09-30: Other Assets, Noncurrent $55.84M.
- 2025-06-30: Other Assets, Noncurrent $57.17M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $65.13M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $59.46M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $55.84M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $57.17M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $73.82M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $65.31M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $77.62M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $71.92M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $67.46M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $61.90M 10-K · filed 2025-02-13 | $72.00M 10-K · filed 2024-02-15 |
| 2023-09-30 | $75.16M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $92.69M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $63.45M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $66.09M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $61.40M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $77.27M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $69.82M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $60.20M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $35.27M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $34.59M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $42.68M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $45.05M 10-K · filed 2022-02-10 | |
| 2020-09-30 | $37.93M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $20.40M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $19.03M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $18.07M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $9.63M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $9.69M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $9.04M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $8.62M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $16.06M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $14.17M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $5.21M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $4.17M 10-K · filed 2019-02-14 | |
| 2017-09-30 | $1.47M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.47M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.47M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $1.56M 10-K · filed 2018-02-15 | |
| 2016-09-30 | $1.56M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.47M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.47M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $1.47M 10-K · filed 2017-02-15 | |
| 2012-12-31 | $101.00K 10-K · filed 2013-02-19 | |
| 2011-12-31 | $839.00K 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |